Illinois § 10

§ 10.

Prescription to authorized entity; use; training. (a) A health care practitioner may prescribe epinephrine injectors in the name of an authorized entity for use in accordance with this Act, and pharmacists and health care practitioners may dispense epinephrine injectors pursuant to a prescription issued in the name of an authorized entity. Such prescriptions shall be valid for a period of 2 years. (b) An authorized entity may acquire and stock a supply of undesignated epinephrine injectors pursuant to a prescription issued under subsection (a) of this Section. Such undesignated epinephrine injectors shall be stored in a location readily accessible in an emergency and in accordance with the instructions for use of the epinephrine injectors. The Department may establish any additional requirements an authorized entity must follow under this Act. (c) An employee or agent of an authorized entity or other individual who has completed training under subsection (d) of this Section may: (1) provide an epinephrine injector to any individual on the property of the authorized entity whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, or to the parent, guardian, or caregiver of such individual, for immediate administration, regardless of whether the individual has a prescription for an epinephrine injector or has previously been diagnosed with an allergy; or (2) administer an epinephrine injector to any individual on the property of the authorized entity whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine injector or has previously been diagnosed with an allergy. (d) An employee, agent, or other individual authorized must complete an anaphylaxis training program before he or she is able to provide or administer an epinephrine injector under this Section. Such training shall be valid for a period of 2 years and shall be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment. The Department shall include links to training providers' websites on its website. Training shall include, but is not limited to: (1) how to recognize signs and symptoms of an allergic reaction, including anaphylaxis; (2) how to administer an epinephrine injector; and (3) a test demonstrating competency of the knowledge required to recognize anaphylaxis and administer an epinephrine injector. Training may also include, but is not limited to: (A) a review of high-risk areas on the authorized entity's property and its related facilities; (B) steps to take to prevent exposure to allergens; (C) emergency follow-up procedures; and (D) other criteria as determined in rules adopted pursuant to this Act. Training may be conducted either online or in person. The Department shall approve training programs and list permitted training programs on the Department's Internet website. (Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.) (Text of Section after amendment by P.A. 104-229) Sec. 10. Prescription to authorized entity; use; training. (a) A health care practitioner may prescribe epinephrine injectors in the name of an authorized entity or authorized individual for use in accordance with this Act, and pharmacists and health care practitioners may dispense epinephrine delivery systems pursuant to a prescription issued in the name of an authorized entity or authorized individual. Such prescriptions shall be valid for a period of 2 years. (a-1) A health care provider with prescribing authority who is employed by or under contract with the Department may issue a statewide standing order for the dispensing of epinephrine delivery systems for use under subsection (c) by authorized individuals or by employees or agents of authorized entities who have completed the training required by subsection (d). (b) An authorized entity or authorized individual may acquire and stock a supply of undesignated epinephrine delivery systems pursuant to a prescription issued under subsection (a) of this Section. Such undesignated epinephrine delivery systems shall be stored in a location readily accessible in an emergency and in accordance with the instructions for use of the epinephrine delivery systems. The Department may establish any additional requirements an authorized entity or authorized individual must follow under this Act. (c) An employee or agent of an authorized entity who is an authorized individual or any other individual who is an authorized individual may: (1) anywhere allergens capable of causing anaphylaxis may be present provide an epinephrine delivery system to any individual whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, or to the parent, guardian, or caregiver of such individual, for immediate administration, regardless of whether the individual has a prescription for an epinephrine delivery system or has previously been diagnosed with an allergy; or (2) anywhere allergens capable of causing anaphylaxis may be present administer an epinephrine delivery system to any individual whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine delivery system or has previously been diagnosed with an allergy. (d) An employee, agent, or other individual authorized must complete an anaphylaxis training program before he or she is able to provide or administer an epinephrine delivery system under this Section. Such training shall be valid for a period of 2 years and shall be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment. The Department shall include links to training providers' websites on its website. Training shall include, but is not limited to: (1) how to recognize signs and symptoms of an allergic reaction, including anaphylaxis; (2) how to administer an epinephrine delivery system; and (3) a test demonstrating competency of the knowledge required to recognize anaphylaxis and administer an epinephrine delivery system. Training may also include, but is not limited to: (A) a review of high-risk areas on the authorized entity's property and its related facilities; (B) steps to take to prevent exposure to allergens; (C) emergency follow-up procedures; and (D) other criteria as determined in rules adopted pursuant to this Act. Training may be conducted either online or in person. The entity or individual conducting the training shall issue a certificate to each person who successfully completes the anaphylaxis training program. The Department shall approve training programs and list permitted training programs on the Department's Internet website. (Source: P.A. 104-229, eff. 1-1-26.)